Combination antiretroviral therapy (cART) component ritonavir significantly alters docetaxel exposure

PURPOSE: Non-AIDS defining cancers (NADCs) now exceed rates of AIDS-defining cancers in HIV-positive patients. Treatment of NADCs may be complicated by drug-drug interactions between antiretrovirals and chemotherapy. Docetaxel is a widely used anticancer agent that is primarily metabolized by CYP3A4...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Rudek, Michelle A, Chang, Cathy Y., Steadman, Kenneth, Johnson, Michael D., Desai, Naveen, Deeken, John F.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3968228/
https://ncbi.nlm.nih.gov/pubmed/24488374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-014-2399-7
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller